Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial

INTERVENTION: experimental group:TCM formula and general treatment based on "Diagnosis and Treatment Program for COVID‐19" (trial version 6th);control group:general treatment based on "Diagnosis and Treatment Program for COVID‐19" (trial version 6th); CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: The time to 2019‐nCoV RNA negativity in patients; SECONDARY OUTCOME: The 7‐point scale;The rate of critcal aggravation;Blood routine test outcomes;Blood biochemical test outcomes; INCLUSION CRITERIA: (1) Comply with the diagnostic criteria for general type COVID‐19 in the "Diagnosis and Treatment Program for COVID‐19"(trial version 6th); (2) Aged >= 18 years; (3) Agree to participate in the trial, and the patient, the legal guardian or the person in charge of the medical institution signed the informed consent through paper signature, electronic signature of mobile phone software, or voice authorization.